STERIS director granted 1,025 restricted stock units

Boulud Pierre reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Boulud Pierre reported acquisition or exercise transactions in this Form 4 filing.

STERIS plc reported that director Pierre Boulud received a grant of 1,025 Career Restricted Stock Units, each representing the right to receive one STERIS ordinary share. The units are fully vested immediately and will be settled in ordinary shares six months after the cessation of the Director's Board service, bringing his reported direct holdings in these units to 1,392.

Insider Trade Summary

Grant/Award: 1,025 shares

Grant/Award 1 txn

Insider Boulud Pierre

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Career Restricted Stock Units F1, F2	1,025	$0.00	$0.00

Holdings After Transaction: Career Restricted Stock Units — 1,392 contracts (Direct)

Footnotes (2)

1. F1. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.
2. F2. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

Key Figures

Career Restricted Stock Units granted: 1,025 units RSU holdings after transaction: 1,392 units Transaction price per unit: $0.0000 +2 more

5 metrics

Career Restricted Stock Units granted 1,025 units Grant of Career Restricted Stock Units to director Pierre Boulud on 2026-08-10

RSU holdings after transaction 1,392 units Total Career Restricted Stock Units reported as directly held after the grant

Transaction price per unit $0.0000 Reported price per Career Restricted Stock Unit for the grant

Underlying ordinary shares per RSU 1 share per unit Each Career Restricted Stock Unit represents one STERIS ordinary share

Settlement timing Six months after cessation of Board service Timing for settlement of RSUs into STERIS ordinary shares

Key Terms

Career Restricted Stock Units, fully vested, settled in STERIS ordinary shares, cessation of the Director's Board service

4 terms

Career Restricted Stock Units financial

"Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share"

fully vested financial

"These Career Restricted Stock Units are fully vested immediately."

settled in STERIS ordinary shares financial

"They will be settled in STERIS ordinary shares six months after the cessation"

cessation of the Director's Board service financial

"six months after the cessation of the Director's Board service."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did STERIS plc (STE) report for Pierre Boulud?

STERIS plc reported that director Pierre Boulud received a grant of 1,025 Career Restricted Stock Units. These units are a form of equity compensation linked to future delivery of STERIS ordinary shares.

How many Career Restricted Stock Units does Pierre Boulud hold after this STE Form 4?

Following the reported grant, Pierre Boulud holds a total of 1,392 Career Restricted Stock Units. This reflects the newly granted 1,025 units added to his previously reported holdings.

When will Pierre Boulud’s Career Restricted Stock Units in STE be settled?

Each Career Restricted Stock Unit will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service, according to the footnote disclosure.

Are the STERIS (STE) Career Restricted Stock Units granted to Pierre Boulud vested?

Yes. The filing states that these Career Restricted Stock Units are fully vested immediately. Although vested, they are deferred and will be settled in shares six months after his Board service ends.

What does each Career Restricted Stock Unit represent for STERIS plc (STE)?

Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share. The shares will be delivered six months after the cessation of the Director's Board service as specified in the footnotes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/12/2026 - 04:32 PM Accepted by SEC EDGAR 08/12/2026 - 04:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Boulud Pierre

(Last) (First) (Middle)

C/O 70 SIR JOHN ROGERSON'S QUAY

(Street)

DUBLIN 2 D02 R296

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
STERIS plc [ STE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Career Restricted Stock Units	(1)	08/10/2026		A		1,025		(2)	(2)	Ordinary Shares	1,025	$0	1,392	D

Explanation of Responses:

1. Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.

2. These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

Remarks:

	/s/ John P. Ubbing, Authorized Representative under Power of Attorney	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)